Clearline Capital’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$320K Hold
34,177
0.01% 103
2025
Q1
$420K Hold
34,177
0.03% 108
2024
Q4
$452K Sell
34,177
-8,018
-19% -$106K 0.06% 92
2024
Q3
$812K Hold
42,195
0.03% 123
2024
Q2
$866K Buy
+42,195
New +$866K 0.02% 120